https://www.selleckchem.com/pr....oducts/abbv-cls-484.
In conclusion, our findings indicate that CD147 is of vital importance for ALK+ ALCL to maintain the high energy demand of rapid cell proliferation, promoting lactate export, and tumor growth. Furthermore, CD147 has the potential to serve as a novel therapeutic target in ALK+ ALCL, and warrants further investigation.Several studies have reported that chronic myeloid leukaemia (CML) patients expressing e14a2 BCRABL1 have a faster molecular response to therapy compared to patients expressing e13a2. To explore the reason for this diff
Beğen
Yorum Yap
Paylaş
